We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.AuthorsCohen SJ; Zalupski MM; Modiano MR; Conkling P; Patt YZ; Davis P; Dorr RT; Boytim ML; Hersh EMPublicationCancer chemotherapy and pharmacology, 2010, Vol 66, Issue 2, p287ISSN1432-0843Publication typearticleDOI10.1007/s00280-009-1162-y